0001209191-21-051912.txt : 20210817
0001209191-21-051912.hdr.sgml : 20210817
20210817170106
ACCESSION NUMBER: 0001209191-21-051912
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210816
FILED AS OF DATE: 20210817
DATE AS OF CHANGE: 20210817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beeler Brian K
CENTRAL INDEX KEY: 0001641580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 211183560
MAIL ADDRESS:
STREET 1: C/O HORIZON PHARMA PLC
STREET 2: 520 LAKE COOK ROAD, SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-16
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001641580
Beeler Brian K
C/O HORIZON THERAPEUTICS PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
0
1
0
0
EVP, General Counsel
Ordinary Shares
2021-08-16
4
M
0
65857
22.14
A
165816
D
Ordinary Shares
2021-08-16
4
S
0
74898
106.00
D
90918
D
Stock Option (Right to Buy)
22.14
2021-08-16
4
M
0
65857
0.00
D
2025-03-22
Ordinary Shares
65857
0
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.6312 to $106.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is fully vested and exercisable.
/s/ Miles W. McHugh, Attorney-in-Fact
2021-08-17